Your browser doesn't support javascript.
loading
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.
Vingiani, Andrea; Agnelli, Luca; Duca, Matteo; Lorenzini, Daniele; Damian, Silvia; Proto, Claudia; Niger, Monica; Nichetti, Federico; Tamborini, Elena; Perrone, Federica; Piccolo, Alberta; Manoukian, Siranoush; Azzollini, Jacopo; Brambilla, Marta; Colombo, Elena; Lopez, Salvatore; Vernieri, Claudio; Marra, Francesca; Conca, Elena; Busico, Adele; Capone, Iolanda; Bozzi, Fabio; Angelini, Marta; Devecchi, Andrea; Salvatori, Rebecca; De Micheli, Valentina; Baggi, Anna; Pasini, Silvia; Jommi, Claudio; Ladisa, Vito; Apolone, Giovanni; De Braud, Filippo; Pruneri, Giancarlo.
Afiliação
  • Vingiani A; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Agnelli L; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Duca M; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Lorenzini D; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Damian S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Proto C; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Niger M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Nichetti F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Tamborini E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Perrone F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Piccolo A; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Manoukian S; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Azzollini J; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Brambilla M; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Colombo E; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Lopez S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Vernieri C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Marra F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Conca E; Gynecologic Oncology, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Busico A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Capone I; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
  • Bozzi F; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Angelini M; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Devecchi A; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Salvatori R; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Micheli V; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Baggi A; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pasini S; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Jommi C; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ladisa V; Precision Cancer Therapeutics Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN.
  • Apolone G; Business Integration Partners S.p.A., Milan, Italy.
  • De Braud F; Business Integration Partners S.p.A., Milan, Italy.
  • Pruneri G; Business Integration Partners S.p.A., Milan, Italy.
JCO Precis Oncol ; 7: e2300067, 2023 07.
Article em En | MEDLINE | ID: mdl-37487147
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article